Aashish Bharara
Physical Medicine & Rehabilitation · Atlanta, GANPI 1881842268
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 129 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $1,045 and has fallen 96.2% since, to $39 in 2024.
Across 129 payments — averaging $21.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nevro Corp.$446
- AbbVie$305
- Amgen$203
- Sunovion Pharmaceuticals Inc.$201
- Upsher-smith Laboratories LLC$189
- Novartis$148
- plus $1K from 31 others
What the payments were for
- Food & beverage$2,715100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nevro Corp. | 3 | $446 |
| AbbVie(2 entities) | 18 | $305 |
| Amgen(2 entities) | 11 | $203 |
| Sunovion Pharmaceuticals Inc. | 12 | $201 |
| Upsher-smith Laboratories LLC | 11 | $189 |
| Novartis | 11 | $148 |
| Smith+Nephew | 4 | $110 |
| UCB, Inc. | 5 | $95 |
| Eisai Inc. | 5 | $94 |
| Radius Health, Inc. | 5 | $82 |
| Abbott | 3 | $67 |
| Kyowa Kirin, Inc. | 4 | $58 |
| CSL Behring | 1 | $56 |
| Boston Scientific | 3 | $54 |
| Theragen, Inc. | 2 | $52 |
| Avanir Pharmaceuticals, Inc. | 3 | $51 |
| Bausch Health US, LLC | 2 | $47 |
| Acorda Therapeutics, Inc | 3 | $45 |
| Axogen | 1 | $36 |
| Johnson & Johnson | 1 | $32 |
| Arbor Pharmaceuticals, Inc. | 2 | $29 |
| Vertical Pharmaceuticals, LLC | 2 | $28 |
| Zyla Life Sciences, Inc. | 2 | $27 |
| Merck | 2 | $27 |
| Zimmer Biomet | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $23 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Biogen | 1 | $16 |
| Aprecia Pharmaceuticals, LLC | 1 | $16 |
| Currax Pharmaceuticals LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Hydrofera LLC | 1 | $15 |
| Saol Therapeutics Inc. | 1 | $15 |
| GE HealthCare | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,715 in reported general payments places this provider in the 80th percentile of 214 physical medicine & rehabilitation providers in Georgia.
See all physical medicine & rehabilitation providers in Georgia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 19 | $176 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in Atlanta
- Erik ShawAtlanta$175K
- Abana AzariahAtlanta$22K
- Michael SchaufeleAtlanta$20K
- Gerald BilskyAtlanta$16K
- Malcolm CarsonAtlanta$9K
- Michael ChuAtlanta$7K
- Michael YochelsonAtlanta$7K
- Derick DavisAtlanta$6K
- Ashish KhannaAtlanta$6K
- Robert GodsallAtlanta$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.